BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38402834)

  • 1. Modulation of the crosstalk between Keap1/Nrf2/HO-1 and NF-κB signaling pathways by Tomatidine protects against inflammation/oxidative stress-driven fulminant hepatic failure in mice.
    Abdulaal WH; Omar UM; Zeyadi M; El-Agamy DS; Alhakamy NA; Ibrahim SRM; Almalki NAR; Asfour HZ; Al-Rabia MW; Mohamed GA; Elshal M
    Int Immunopharmacol; 2024 Mar; 130():111732. PubMed ID: 38402834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective Role of 4-Octyl Itaconate in Murine LPS/D-GalN-Induced Acute Liver Failure via Inhibiting Inflammation, Oxidative Stress, and Apoptosis.
    Li R; Yang W; Yin Y; Zhang P; Wang Y; Tao K
    Oxid Med Cell Longev; 2021; 2021():9932099. PubMed ID: 34457120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective Effects of Sesquiterpenoids from the Root of Panax ginseng on Fulminant Liver Injury Induced by Lipopolysaccharide/d-Galactosamine.
    Wang W; Zhang Y; Li H; Zhao Y; Cai E; Zhu H; Li P; Liu J
    J Agric Food Chem; 2018 Jul; 66(29):7758-7763. PubMed ID: 29974747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of sea buckthorn polysaccharide extracts against LPS/d-GalN-induced acute liver failure in mice via suppressing TLR4-NF-κB signaling.
    Liu H; Zhang W; Dong S; Song L; Zhao S; Wu C; Wang X; Liu F; Xie J; Wang J; Wang Y
    J Ethnopharmacol; 2015 Dec; 176():69-78. PubMed ID: 26494508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Geraniol protects against lipopolysaccharide and D-galactosamine-induced fulminant hepatic failure by activating PPARγ.
    Li Y; Wang N; Jiang Y
    Microb Pathog; 2019 Mar; 128():7-12. PubMed ID: 30550845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NLRP3 inflammasome activation in D-galactosamine and lipopolysaccharide-induced acute liver failure: role of heme oxygenase-1.
    Kim SJ; Lee SM
    Free Radic Biol Med; 2013 Dec; 65():997-1004. PubMed ID: 23994575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced hepatic injury in Toll-like receptor 4-deficient mice following D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure.
    Ben Ari Z; Avlas O; Pappo O; Zilbermints V; Cheporko Y; Bachmetov L; Zemel R; Shainberg A; Sharon E; Grief F; Hochhauser E
    Cell Physiol Biochem; 2012; 29(1-2):41-50. PubMed ID: 22415073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mangiferin Attenuates LPS/D-GalN-Induced Acute Liver Injury by Promoting HO-1 in Kupffer Cells.
    Yang S; Kuang G; Zhang L; Wu S; Zhao Z; Wang B; Yin X; Gong X; Wan J
    Front Immunol; 2020; 11():285. PubMed ID: 32158448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein A5 alleviates LPS/D-GalN-induced fulminant liver failure in mice by inhibiting TLR4-mediated NF-κB pathway.
    Tao YC; Wang ML; Wu DB; Luo C; Tang H; Chen EQ
    J Transl Med; 2019 May; 17(1):151. PubMed ID: 31077206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of SKLB010 against D-galactosamine/lipopolysaccharide-induced acute liver failure via nuclear factor-κB signaling pathway in macrophages.
    Xie C; Jingjing W; Li X; Zeng F; Ma L; Li C; Wei Z; Peng A; Chen L
    Int Immunopharmacol; 2014 Aug; 21(2):261-8. PubMed ID: 24861250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of α-lipoic acid in LPS/d-GalN induced fulminant hepatic failure in mice: studies on oxidative stress, inflammation and apoptosis.
    Xia X; Su C; Fu J; Zhang P; Jiang X; Xu D; Hu L; Song E; Song Y
    Int Immunopharmacol; 2014 Oct; 22(2):293-302. PubMed ID: 25046589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CQMUH-011, a novel adamantane sulfonamide compound, inhibits lipopolysaccharide- and D-galactosamine-induced fulminant hepatic failure in mice.
    Yan L; Hu X; Wu Q; Jiang R; Zhang S; Ling Q; Liu H; Jiang X; Wan J; Liu Y
    Int Immunopharmacol; 2017 Jun; 47():231-243. PubMed ID: 28433945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatoprotective effect of α-mangostin against lipopolysaccharide/d-galactosamine-induced acute liver failure in mice.
    Fu T; Li H; Zhao Y; Cai E; Zhu H; Li P; Liu J
    Biomed Pharmacother; 2018 Oct; 106():896-901. PubMed ID: 30119260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Andrographolide ameliorates d-galactosamine/lipopolysaccharide-induced acute liver injury by activating Nrf2 signaling pathway.
    Pan CW; Yang SX; Pan ZZ; Zheng B; Wang JZ; Lu GR; Xue ZX; Xu CL
    Oncotarget; 2017 Jun; 8(25):41202-41210. PubMed ID: 28465482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endotoxin tolerance ameliorates lipopolysaccharide/D-galactosamine-induced acute liver failure by negative regulation of the NF-κB/NLRP3 and activation of Nrf2/HO-1 via Sitr1.
    Shi H; Xie X; Zheng S; Chen H; Liu C; Li S; Lu M
    Int Immunopharmacol; 2024 May; 132():111994. PubMed ID: 38581992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effects of morin on lipopolysaccharide/d-galactosamine-induced acute liver injury by inhibiting TLR4/NF-κB and activating Nrf2/HO-1 signaling pathways.
    Tian Y; Li Z; Shen B; Zhang Q; Feng H
    Int Immunopharmacol; 2017 Apr; 45():148-155. PubMed ID: 28213269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atractylodin ameliorates lipopolysaccharide and d-galactosamine-induced acute liver failure via the suppression of inflammation and oxidative stress.
    Lyu Z; Ji X; Chen G; An B
    Int Immunopharmacol; 2019 Jul; 72():348-357. PubMed ID: 31030090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S-allylmercaptocysteine ameliorates lipopolysaccharide-induced acute lung injury in mice by inhibiting inflammation and oxidative stress via nuclear factor kappa B and Keap1/Nrf2 pathways.
    Mo M; Li S; Dong Z; Li C; Sun Y; Li A; Zhao Z
    Int Immunopharmacol; 2020 Apr; 81():106273. PubMed ID: 32070920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hepatoprotective effect of myricetin against lipopolysaccharide and D-galactosamine-induced fulminant hepatitis.
    Lv H; An B; Yu Q; Cao Y; Liu Y; Li S
    Int J Biol Macromol; 2020 Jul; 155():1092-1104. PubMed ID: 31712142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Madecassoside prevents acute liver failure in LPS/D-GalN-induced mice by inhibiting p38/NF-κB and activating Nrf2/HO-1 signaling.
    Wang W; Wu L; Li Q; Zhang Z; Xu L; Lin C; Gao L; Zhao K; Liang F; Zhang Q; Zhou M; Jiang W
    Biomed Pharmacother; 2018 Jul; 103():1137-1145. PubMed ID: 29715757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.